Private therapeutic neurotechnology company founded by Jacob Robinson, Sameer Sheth and Sunil Sheth. Develops investigational XCS/DOT microstimulation technology for treatment-resistant depression; 2026 IDE permits a clinical study, not marketing.
Founded 2022
$18M 2024-01-24 Arboretum Ventures , Dolby Family Ventures , KdT Ventures , Satori Neuro , re.Mind Capital , Max Hodak , Divergent Capital , TMC Innovation , PsyMed Ventures , Empath Ventures , Capital Factory
SHOW MORE
team@apexlogos.ai · 17 hours ago
BCI research snapshot, reviewed 2026-10-06. Company identity: MotifNeurotech. This is the pre-import evidence dossier; historical statements about database absence or review are archival. Unverified claims remain research leads, not validated facts.
Part 1/1
# Motif Neurotech
Research date / sources accessed: **2026-10-06**. Review document only; no database mutations.
## Entity and pasted-list validation
**Real private company**, Motif Neurotech, Inc.; official site [motifneuro.tech](https://motifneuro.tech/ ). Houston, Texas and Jacob Robinson founder/CEO are verified by the [company page](https://motifneuro.tech/company ). Founded in 2022 according to the [2024 launch-pad announcement](https://www.prnewswire.com/news-releases/rice-biotech-launch-pad-startup-motif-neurotech-closes-series-a-financing-of-18-75-million-302042601.html ). An active therapeutic neurotechnology company, whose XCS System is investigational: [2026 company announcement](https://www.businesswire.com/news/home/20260427361988/en/Motif-Neurotech-Receives-FDA-Approval-to-Begin-First-Clinical-Trial-of-its-Therapeutic-BCI-for-Treatment-Resistant-Depression ) reports FDA IDE permission for the RESONATE early feasibility study. This is permission to test, not authorization to market depression treatment. The pasted “brain pacemaker” is a descriptive label: older financing named DOT microstimulator; the current clinical program uses XCS. Pasted **$30M+ total is unverified**; do not import it as a verified cumulative amount.
## Existing adex match
Exact record `MotifNeurotech` exists, with description “Rice Biotech Launch Pad startup developing an implantable device for treatment-resistant depression.” Its extra links motifneuro.tech and the $18.75M financing. Other `Motif`, `MotifAnalytics`, `UMotif`, and `GoldiLeitmotif` are not equivalent. Recommendation: enrich existing exact record after review.
## Images and leadership
Official company profile/social cover (not a square logo): [Direct OG image](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd829/672c322bd48e19f84a773415_Company%20-%20Open%20Graph.png ), extracted from `og:image` in [company HTML](https://motifneuro.tech/company ). Person pictures below are actual `img src` assets, not guessed paths. HTTP status verification is recorded separately below when available.
| Person | Role / timing | Profile / evidence | Direct profile-picture URL |
|---|---|---|---|
| Jacob Robinson | Co-founder & CEO, current | [Official profile/team](https://motifneuro.tech/company ) | [Image](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd852/673e252ef8066aed9ba9220e_jacob-robinson.png ) |
| Sameer Sheth | Founder; current company founder profile | [Official profile/team](https://motifneuro.tech/company ) | [Image](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd852/671bc5b6f9174731bd5bd8e1_Sameer_Sheth_Motif_Neurotech.webp ) |
| Sunil Sheth | Founder; current company founder profile | [Official profile/team](https://motifneuro.tech/company ) | [Image](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd852/671bc5b6f9174731bd5bdacf_Sheth-Sunil-.png ) |
| Nick Halper | COO, current | [Official profile/team](https://motifneuro.tech/company ) | [Image](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd852/671bc5b6f9174731bd5bda21_Nick_Halper__Motif_Neurotech.webp ) |
| Steve Goetz | CTO, current | [Official profile/team](https://motifneuro.tech/company ) | [Image](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd852/671bc5b6f9174731bd5bda8b_steve-goetz_motif-neurotech.jpg ) |
The official page also exposes engineering/team and advisor portraits; these should not be confused with officers. Examples: [Amanda Singer](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd852/6721624ddb3f964652a2c720_Amanda%201.jpg ), [Ameya Nanivadekar](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd852/671bc5b6f9174731bd5bd95b_Ameya_Nanivadekar_Motif%20Neurotech.webp ), [Amy Kruse](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd852/672162f2db3f964652a378d9_Amy%20Kruse.jpg ), [Tom Shehab](https://cdn.prod.website-files.com/671bc5b6f9174731bd5bd852/671bc5b6f9174731bd5bd97b_Tom-Shehab_Motif_Neurotech.webp ). Role evidence is the [company roster](https://motifneuro.tech/company ).
## Sourced investments
| Announced | Amount / currency | Instrument | Lead | Other named investors | Evidence |
|---|---|---|---|---|---|
| 2024-01-24 | USD 18.75M | Series A equity | Arboretum Ventures | KdT Ventures, Satori Neuro, Dolby Family Ventures, re.Mind Capital, Max Hodak; existing Divergent Capital, TMC Innovation, PsyMed Ventures, Empath Ventures, Capital Factory | [Company-issued announcement](https://www.prnewswire.com/news-releases/rice-biotech-launch-pad-startup-motif-neurotech-closes-series-a-financing-of-18-75-million-302042601.html ); [transaction counsel](https://www.wsgr.com/print/v2/content/49016904/Wilson-Sonsini-Advises-Motif-Neurotech-on-%2418.75-Million-Series-A-Financing.pdf ) |
No verified exhaustive prior-round schedule or subsequent round supporting $30M+ was found. Robinson’s $40M+ research grants at Rice describe his academic lab history, not Motif corporate financing; exclude those from company totals. No verified acquisition or IPO found in consulted primary sources.
## Review / import decision
Enrich exact existing company with current founders and officers; retain investor names as candidate identities until reviewed. Use clinical-stage status and XCS/DOT product timeline. Hold cumulative funding field pending a complete round ledger; no clinical efficacy or marketing authorization inferred from the IDE. SHOW MORE
Jacob RobinsonCo-founder & CEO
Nick HalperCOO
Sameer ShethFounder
Steve GoetzCTO
Sunil ShethFounder